Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Nicholas Hall Group of Companies | PRODUCT CODE: 1229682

Cover Image

PUBLISHER: Nicholas Hall Group of Companies | PRODUCT CODE: 1229682

New Paradigms for CHC 2023: The Future Resumed

PUBLISHED:
PAGES: 303 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Site License)
USD 20640
PDF (Global License)
USD 25800

Add to Cart

“Paradigms for CHC 2023: The Future Resumed”, a signature report personally written by Nicholas Hall, who is supported by a team of researches focusing on specific topics including Sustainability, e-Commerce, Competition, Switch and Demographics.

Nicholas will examine key trends impacting the consumer healthcare market, providing the ultimate strategic guide to navigating the CHC landscape of today and in the future.

The report also comes with the option to purchase additional customised in-house presentations and optional quarterly updates of the situation.

SAMPLE VIEW


Table of Contents

1. So What's the Big Idea?

  • The global CHC market
  • 10 Steps to Heaven
    • 1. CBD, a long-distance race!
    • 2. Mental Wellness: Problems highlighted by the pandemic
    • 3. Sexual Health & Fertility
    • 4. Women's Health, Ageing
    • 5. Sustainability
    • 6. Natural & Organic Products
    • 7. Food Intolerance
    • 8. E-commerce
    • 9. AI
    • 10. Emerging Markets
  • The Big Ideas addressed in this report
  • The 2024 Strategic Narrative

2. Covid & Its Aftermath

  • How Covid-19 accelerated the shift to Self-Care
  • Historical impact of recession on Consumer Healthcare
  • The shifting landscape of consumer behaviour
  • Growth categories during the pandemic
  • Rethinking supply chains: how the pandemic exposed vulnerabilities

3. Classic Categories

  • Analgesics: Few major opportunities so marketers filling in gaps
  • Cough, Cold & Allergy: Heavily dependent on seasonal illness trends
  • Gastrointestinals: New consumer benefits drive expansion
  • Vitamins, Minerals & Supplements: Trusted science key to growth
  • Dermatologicals: Resistant to growth
  • Lifestyle CHC: A full spectrum of herbals to Rx-to-OTC switches

4. How to Innovate

  • Why does the ratio of high-quality (3 and 4 star) innovations remain persistently low?
  • Future microbiome and probiotics innovation will be driven by investment in clinical research
  • Improved diagnostics will support VMS innovation and Rx-to-OTC switch
  • Demand for diabetes prevention and management is giving fuel to supplement and diagnostic innovation
  • Quality science and consumer trust key to successful weight loss innovation
  • Demand for products promoting mental health and sleep growing post-pandemic
  • Ageing demographic underpins supplement and plant-based protein innovation
  • Focus on analgesics: New formats, switch and ingredient combinations drive innovation
  • Focus on CCA: Natural-based formulations and allergy switches power NPD activity
  • Focus on dermatologicals: Sustainable packaging and cutting-edge apps fuel NPD
  • Focus on GIs / probiotics: Hangover cures, prebiotics and switch are key
  • What does the future hold? Evolving NPD trends, personalisation, emerging niches

5. Rx-to-OTC Switch

  • Rx-to-OTC switch in the healthcare ecosystem
  • Why Switch?
  • The uptake in telehealth & telemedicine
  • Switch in Europe
  • Can Switch be successful only in the USA?
  • Voltaren Arthritis Pain: USA Switch journey
  • US FDA's Additional Condition for Nonprescription Use (ACNU)
  • Innovation hot spots in Switch
  • Switch case studies
  • On the horizon?

6. Demographic Timebomb

  • A rapidly Growing Middle Class in expanding urban areas
  • Generation cohorts: different attitudes & behaviours to health
  • What is Middle Class?
  • The three most important demographic groups
  • What about men?
  • Is there a Gender Gap?

7. Women's Healthcare: Listening to the Female Voice

  • Women vs men
  • Women's leading CHC role
  • Menstrual pain and PMS
  • Are the OTC contraception floodgates about to open?
  • Menopause - are there new growth opportunities?
  • Overactive bladder - OTC growth category or destined for failure?
  • New thinking on endometriosis
  • Women's brands and companies

8. Health Through Digestion

  • The importance of the gut microbiome
  • Mental health is a growth segment for probiotics
  • Custom probiotics have the potential to disrupt
  • The "biotics" family
  • The "Gut-Muscle Axis"; a new dimension for probiotics?
  • Food allergies: the focus of much research
  • Food intolerance
  • Unhealthy lifestyles are driving demand for digestive remedies and other GIs
  • Hangover cures form a new segment
  • ORTs repositioning as lifestyle products

9. Mental Wellness

  • Mental health problems soared during Covid-19, while economic worries are a continuing contributor to stress
  • Spending on mental health & wellbeing remains a priority for consumers
  • WHO declares a sleep pandemic
  • Sleep quality is a top health priority for consumers
  • ZzzQuil: Highly successful sleep aid, with 3 key development stages
  • Is the sales boost in sedatives & sleep aids sustainable?
  • New indications and ingredients in mental wellness
  • CBD for sleep & anxiety?

10. Cannabis

  • A note on defining the market
  • North America
  • Europe
  • Asia-Pacific

11. Sexual Health & Fertility

  • Huge potential for daily OCs worldwide
  • Education is central to expanding the reach of EHC
  • Is a male contraceptive pill viable and is there demand?
  • Condoms: Little NPD potential, so other ways to swell sales needed
  • Menstrual pain / PMS market expands via launch activity
  • Intimate care shows plenty of scope for expansion
  • Menopause: UK sees the first over-the-counter HRT, while a new
  • Rx drug may revolutionise treatment
  • How big can the OTC ED market become?
  • Do topicals represent a viable ED alternative?
  • Can premature ejaculation treatments find a wider audience?
  • Prenatal vitamins prove fertile ground for NPD

12. Obesity & Related Conditions

  • Obesity is a huge determinant of health - and the data is frightening
  • Obesity crisis represents huge opportunity for CHC
  • Where are the opportunities?
  • Evidence-backed brands can be lost among the plethora of weight loss supplements & meal replacements
  • Supporting consumers on their weight loss journey
  • Apps & wearables for weight loss
  • Semaglutide: Is the excitement justified?
  • Obesity's link to other health conditions brings possibilities

13. Digital Revolution

  • AI and chatbots
  • Accessibility of data
  • Medtech & wearables
  • Apps
  • Telehealth
  • Digital communication

14. Sustainability

  • Frameworks become regulations
  • The Triple Bottom Line: People, Planet, Profit
  • Environmental, Social & Governance (ESG) Reporting
  • Collaborate to make progress
  • Innovation, packaging & recycling - drafting a roadmap to a circular economy
  • Engineering, beauty & performance with environmental credentials
  • Communicating sustainability
  • Being in the Wellbeing Business

15. Emerging Markets

  • Emerging Markets: attractive markets with some degree of uncertainty
  • Emerging Markets forecasts
  • Emerging Markets: What's holding back growth?
  • CHC performance in selected Emerging Markets
  • Nicholas Hall's 20 ways to succeed in the Emerging Markets

16. China

  • China plans an economic reset
  • Should I stay, or should I go?
  • Lockdown easing brings a more positive outlook for CHC
  • Despite a weakened economy, China's CHC market rebounded well
  • Population imbalance: the issues & opportunities of an ageing population
  • Gen X goes green and young women lead online shopping trends
  • "Sang culture" and "Me mentality" prevalent as consumers focus on health & wellness
  • Covid-19 changes consumer preferences from overseas supplements to TCM
  • China's fragmented pharma market starting to consolidate
  • The NMPA seeks to incentivise innovation
  • Technological advances: AI and R&D
  • How to get ahead online
  • Competition for e-commerce giants amid regulatory clampdown
  • CHC product trends & opportunities
  • Summary: What does all this mean for CHC players in China?

17. Distribution

  • Overview
  • Retail Category Management
  • Pharmacy Point-of-Care
  • In-store clinic model
  • Leading pharmacy chains
  • Private label
  • General Sales List and self-selection
  • Mass market
  • E-commerce
  • Thorne: Digitally-native personalised supplement brand with diagnostics presence
  • Subscription model
  • Shopper insights
  • Patient / consumer journey

18. Competition

  • Cluster Analysis 1: MNCs + True Pharma
  • Cluster Analysis 2: MNCs + FMCG
  • Cluster Analysis 3: Regional Players + True Pharma
  • Cluster Analysis 4: Regional Players + FMCG

19. M&A

  • Why M&A?
  • Type of M&A models
  • High acquisition multiples
  • Ten Golden Rules of M&A

20. Managing Brands for Long-Term Growth

  • Building trust in a brand beyond its science
  • Managing price increases
  • Tactics that could drive brand share in a static market
  • How to compete in an industry dominated by generics
  • How to leverage the New Paradigm
  • WOW! Brands case studies: Innovation & scale
  • Olly: Dynamic US brand, with supplements portfolio targeting female Millennials
  • Lumify: Rx-to-OTC Switch eye care brand with heavy focus on cosmetic red eye benefits, backed by professional recommendation
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!